| Literature DB >> 31988391 |
George V Sharonov1,2,3, Ekaterina O Serebrovskaya2,3, Diana V Yuzhakova1, Olga V Britanova1,2,3, Dmitriy M Chudakov4,5,6,7.
Abstract
Recent data show that B cells and plasma cells located in tumours or in tumour-draining lymph nodes can have important roles in shaping antitumour immune responses. In tumour-associated tertiary lymphoid structures, T cells and B cells interact and undergo cooperative selection, specialization and clonal expansion. Importantly, B cells can present cognate tumour-derived antigens to T cells, with the functional consequences of such interactions being shaped by the B cell phenotype. Furthermore, the isotype and specificity of the antibodies produced by plasma cells can drive distinct immune responses. Here we summarize our current knowledge of the roles of B cells and antibodies in the tumour microenvironment. Moreover, we discuss the potential of using immunoglobulin repertoires as a source of tumour-specific receptors for immunotherapy or as biomarkers to predict the efficacy of immunotherapeutic interventions.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31988391 DOI: 10.1038/s41577-019-0257-x
Source DB: PubMed Journal: Nat Rev Immunol ISSN: 1474-1733 Impact factor: 53.106